These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9372997)

  • 1. Management of hypercholesterolemia: practice patterns for primary care providers and cardiologists.
    Bramlet DA; King H; Young L; Witt JR; Stoukides CA; Kaul AF
    Am J Cardiol; 1997 Oct; 80(8B):39H-44H. PubMed ID: 9372997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary prevention in a cardiology group practice and hospital setting after a heart-care initiative.
    LaBresh KA; Owen P; Alteri C; Reilly S; Albright PS; Hordes AR; Shaftel PA; Noonan TE; Stoukides CA; Kaul AF
    Am J Cardiol; 2000 Feb; 85(3A):23A-29A. PubMed ID: 10695704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of practice setting on quality of lipid-lowering management in patients with coronary artery disease.
    Harnick DJ; Cohen JL; Schechter CB; Fuster V; Smith DA
    Am J Cardiol; 1998 Jun; 81(12):1416-20. PubMed ID: 9645890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Achieving National Cholesterol Education Program goals for low-density lipoprotein cholesterol in cardiac patients: importance of diet, exercise, weight control, and drug therapy.
    Allison TG; Squires RW; Johnson BD; Gau GT
    Mayo Clin Proc; 1999 May; 74(5):466-73. PubMed ID: 10319076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid management in a private cardiology practice (the Midwest Heart experience).
    Brown AS; Cofer LA
    Am J Cardiol; 2000 Feb; 85(3A):18A-22A. PubMed ID: 10695703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementing quality assurance programs in multigroup practices for treating hypercholesterolemia in patients with coronary artery disease.
    Gerber J
    Am J Cardiol; 1997 Oct; 80(8B):57H-61H. PubMed ID: 9373000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Achieving National Cholesterol Education Program goals in coronary artery disease.
    Rondina MT; Zebrack JS
    Prev Cardiol; 2005; 8(1):18-22. PubMed ID: 15722690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physician noncompliance with the 1993 National Cholesterol Education Program (NCEP-ATPII) guidelines.
    Frolkis JP; Zyzanski SJ; Schwartz JM; Suhan PS
    Circulation; 1998 Sep; 98(9):851-5. PubMed ID: 9738639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current lipid management and low cholesterol goal attainment in common daily practice in Spain. The REALITY Study.
    García Ruiz FJ; Marín Ibáñez A; Pérez-Jiménez F; Pintó X; Nocea G; Ahumada C; Alemao E; Yin D;
    Pharmacoeconomics; 2004; 22 Suppl 3():1-12. PubMed ID: 15669149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low high-density lipoprotein cholesterol and other coronary heart disease risk factors in patients with total cholesterol levels greater than 5.17 mmol/L (200 mg/dL) in family practice. A report from CEN.
    J Am Board Fam Pract; 1991; 4(5):285-97. PubMed ID: 1746296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-density lipoproteins and risk for coronary artery disease.
    Ballantyne CM
    Am J Cardiol; 1998 Nov; 82(9A):3Q-12Q. PubMed ID: 9819098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.
    deGoma EM; Ahmad ZS; O'Brien EC; Kindt I; Shrader P; Newman CB; Pokharel Y; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
    Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical treatment and secondary prevention of coronary heart disease in general practice in Iceland.
    Sigurdsson EL; Jónsson JS; Thorgeirsson G
    Scand J Prim Health Care; 2002 Mar; 20(1):10-5. PubMed ID: 12086276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consistency of lipid-altering effects of ezetimibe/simvastatin across gender, race, age, baseline low density lipoprotein cholesterol levels, and coronary heart disease status: results of a pooled retrospective analysis.
    Ose L; Shah A; Davies MJ; Rotonda J; Maccubbin D; Tribble D; Veltri E; Mitchel Y
    Curr Med Res Opin; 2006 May; 22(5):823-35. PubMed ID: 16709304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart disease in the assessment and treatment of hypercholesterolemia: coronary artery disease and other atherosclerotic disease, family history, and left ventricular hypertrophy.
    Gotto AM
    Am J Med; 1994 Jun; 96(6A):9S-18S. PubMed ID: 8017474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nurse case management of hypercholesterolemia in patients with coronary heart disease: results of a randomized clinical trial.
    Allen JK; Blumenthal RS; Margolis S; Young DR; Miller ER; Kelly K
    Am Heart J; 2002 Oct; 144(4):678-86. PubMed ID: 12360165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Statins in primary prevention of coronary heart disease].
    Paulweber B
    Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of high blood cholesterol by primary care physicians: diffusion of the National Cholesterol Education Program Adult Treatment Panel guidelines.
    Shea S; Gemson DH; Mossel P
    J Gen Intern Med; 1990; 5(4):327-34. PubMed ID: 2374043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale for effective treatment of hypercholesterolemia.
    Marcus AO
    Am J Cardiol; 1996 Sep; 78(6A):4-12. PubMed ID: 8875969
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.